The estimated Net Worth of Paolo Fundaro is at least $201 Milhão dollars as of 13 August 2020. Mr. Fundaro owns over 1,500,000 units of Intercept Pharmaceuticals Inc stock worth over $76,000,000 and over the last 12 years he sold ICPT stock worth over $124,973,709. In addition, he makes $341,356 as Independent Chairman of the Board at Intercept Pharmaceuticals Inc.
Paolo has made over 8 trades of the Intercept Pharmaceuticals Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently he sold 1,500,000 units of ICPT stock worth $71,250,000 on 13 August 2020.
The largest trade he's ever made was selling 1,500,000 units of Intercept Pharmaceuticals Inc stock on 13 August 2020 worth over $71,250,000. On average, Paolo trades about 78,667 units every 95 days since 2012. As of 13 August 2020 he still owns at least 4,000,000 units of Intercept Pharmaceuticals Inc stock.
You can see the complete history of Mr. Fundaro stock trades at the bottom of the page.
Paolo Fundaro serves as Independent Chairman of the Board of the Company. Mr. Fundarò has been Chief Financial Officer of Genextra S.p.A., an investment firm focused on the life sciences industry, since its inception in 2004. Mr. Fundarò also has served as Managing Director of certain of Genextra’s portfolio companies, including Congenia S.r.l. since 2004, Dac S.r.l. from 2004 until December 2016 and Tethis S.p.A. from 2004 until July 2016. Before joining Genextra, Mr. Fundarò was Director of Finance and Strategic Planning for the Fastweb Group from 2000 to 2004. Earlier in his career, Mr. Fundarò worked for investment banks Salomon Smith Barney (now Citigroup) and Donaldson, Lufkin & Jenrette (now Credit Suisse). Mr. Fundarò serves on the board of directors of a number of private companies. Mr. Fundarò received a degree in Business Management from Bocconi University in Milan, Italy.
As the Independent Chairman of the Board of Intercept Pharmaceuticals Inc, the total compensation of Paolo Fundaro at Intercept Pharmaceuticals Inc is $341,356. There are 10 executives at Intercept Pharmaceuticals Inc getting paid more, with Mark Pruzanski having the highest compensation of $6,615,780.
Paolo Fundaro is 46, he's been the Independent Chairman of the Board of Intercept Pharmaceuticals Inc since 2015. There are 22 older and 2 younger executives at Intercept Pharmaceuticals Inc. The oldest executive at Intercept Pharmaceuticals Inc is Keith Gottesdiener, 66, who is the Independent Director.
Paolo's mailing address filed with the SEC is C/O INTERCEPT PHARMACEUTICALS, INC., 305 MADISON AVENUE, MORRISTOWN, NJ, 07960.
Over the last 12 years, insiders at Intercept Pharmaceuticals Inc have traded over $1,530,243,701 worth of Intercept Pharmaceuticals Inc stock and bought 2,408,920 units worth $77,118,364 . The most active insiders traders include Srinivas Akkaraju, Jonathan Silverstein, eFrancesco Micheli. On average, Intercept Pharmaceuticals Inc executives and independent directors trade stock every 10 days with the average trade being worth of $1,114,673. The most recent stock trade was executed by Srinivas Akkaraju on 10 March 2021, trading 237,000 units of ICPT stock currently worth $5,017,290.
we are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary cholangitis (pbc), nonalcoholic steatohepatitis (nash), primary sclerosing cholangitis (psc) and biliary atresia. in a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with progressive, non-viral liver disease. we are committed to improving patients’ lives and addressing the liver community’s most pressing needs. our corporate headquarters is located in new york, and we have additional offices in san diego, london and perugia. for more information about intercept, please visit our website at: www.interceptpharma.com and follow us on twitter at: @interceptpharma.
Intercept Pharmaceuticals Inc executives and other stock owners filed with the SEC include: